Schizophrenia drugs work poorly, study suggests
But psychiatrists laud distinctions drawn
The biggest study ever of drugs for schizophrenia should help psychiatrists get away from trial and error in treating their patients with the debilitating mental illness, its authors said yesterday. But the $44 million federally funded research project also reached a much darker conclusion: None of the drugs works very well. (Full article: 829 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
Waiting for Twitter to feed in the latest...